Patient Programs News Today

/PRNewswire/ -- ProductLife Group (PLG), the specialised global provider of regulatory, scientific, vigilance, quality and digital transformation consulting...

Niraparib and abiraterone acetate (Akeega; Janssen Pharmaceutical Companies of Johnson & Johnson) is the first-and-only dual action tablet that combines a PARP inhibitor with abiraterone acetate administered with prednisone.

The FDA has approved FoundationOne CDx to be utilized as a companion diagnostic for the dual-action tablet of niraparib plus abiraterone acetate, which was approved for use in combination with prednisone in adult patients with deleterious or suspected deleterious BRCA-mutated metastatic castration-resistant prostate cancer.

Atrium Health Levine Children’s Hospital is set to open its new pediatric outpatient treatment center.

Insurance companies and pbms is sky rocketing. >> reporter: thats because insurers dont always pass on the savings according to consumers. >> thats why we called for an end to the rebate system. its driving up the price of insulin. its also reducing the choices people have. >> i have been rationing my insulin for three year. >> reporter: with no health insurance, champion has been taking fraction of her recommended dose a practice thats all too common. >> no one should go without i.n.s. tkeupb. ...